269 related articles for article (PubMed ID: 16405511)
1. Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis.
Broccolini A; Gidaro T; Morosetti R; Gliubizzi C; Servidei T; Pescatori M; Tonali PA; Ricci E; Mirabella M
J Neurochem; 2006 Feb; 96(3):777-89. PubMed ID: 16405511
[TBL] [Abstract][Full Text] [Related]
2. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle.
Broccolini A; Gidaro T; De Cristofaro R; Morosetti R; Gliubizzi C; Ricci E; Tonali PA; Mirabella M
J Neurochem; 2008 May; 105(3):971-81. PubMed ID: 18182043
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers.
Nogalska A; Engel WK; McFerrin J; Kokame K; Komano H; Askanas V
J Neurochem; 2006 Mar; 96(5):1491-9. PubMed ID: 16441512
[TBL] [Abstract][Full Text] [Related]
4. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
[TBL] [Abstract][Full Text] [Related]
6. Increased aging in primary muscle cultures of sporadic inclusion-body myositis.
Morosetti R; Broccolini A; Sancricca C; Gliubizzi C; Gidaro T; Tonali PA; Ricci E; Mirabella M
Neurobiol Aging; 2010 Jul; 31(7):1205-14. PubMed ID: 18823681
[TBL] [Abstract][Full Text] [Related]
7. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of inclusion body myositis.
Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
11. The effect of relaxin treatment on skeletal muscle injuries.
Negishi S; Li Y; Usas A; Fu FH; Huard J
Am J Sports Med; 2005 Dec; 33(12):1816-24. PubMed ID: 16157846
[TBL] [Abstract][Full Text] [Related]
12. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
13. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
14. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
[TBL] [Abstract][Full Text] [Related]
15. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.
Arnardottir S; Borg K; Ansved T
J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):917-20. PubMed ID: 15146016
[TBL] [Abstract][Full Text] [Related]
16. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
17. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
Fidziańska A; Glinka Z
Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
[TBL] [Abstract][Full Text] [Related]
18. Androgens regulate neprilysin expression: role in reducing beta-amyloid levels.
Yao M; Nguyen TV; Rosario ER; Ramsden M; Pike CJ
J Neurochem; 2008 Jun; 105(6):2477-88. PubMed ID: 18346198
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA degradation may be inhibited in sporadic inclusion body myositis.
Nakano S; Shinde A; Ito H; Ito H; Kusaka H
Neurology; 2005 Aug; 65(3):420-5. PubMed ID: 16087907
[TBL] [Abstract][Full Text] [Related]
20. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]